Vaccination Rates: England

Debate between Jen Craft and Danny Beales

Thursday 3rd September 2026 Westminster Hall

[Danny Beales (Uxbridge and South Ruislip) (Lab)]

I beg to move,

That this House has considered vaccination rates in England.

It is an honour to serve under your chairship today, Mrs Barker. I am pleased to co-sponsor this debate alongside colleagues from the Health and Social Care Committee who are also here today.

It is very easy, from the vantage point of the 21st century, to forget that about half of children used to die before the age of 15 from infection and disease. Thankfully, we now have vaccines and our routine vaccination schedule providing protection against 15 preventable infections across our lifetimes. For decades, our system was one of the best in the world. The childhood diseases that used to cause so much suffering—measles, polio and others—sound like things from history books. I am sure we all have memories of our early school-based vaccinations and flu jabs in the winter period, and the joy of the discovery of the covid-19 vaccine and the hope it brought of a return to normality. So why have this debate today? Because, despite a seemingly continued record of progress and innovation since 2012, our vaccination system has been sleepwalking into a crisis.

The percentage of eligible people getting the major vaccines has been falling year on year, dropping below the 95% coverage recommended by the World Health Organisation to prevent onward transmission. We have now undoubtedly hit a crisis point. Across England as a whole, the 95% target is not being met for any routine childhood vaccination programme and many adult programmes. For example, in 2024-25, only 83.7% of five-year-olds in England had both doses of the measles, mumps and rubella vaccine. In my own constituency, the figure is even lower, at 74%. We are now seeing measles outbreaks in our cities and, shockingly, we have lost our measles elimination status nationally. Tragically, three children died this year from measles—a totally preventable illness.

When questioned about these issues at the Health and Social Care Committee, officials assured us that actions were under way and the tide was turning, but the most recent vaccine stats, released at the end of August, unfortunately show a continued downward trend. The 6-in-1 vaccine dose three coverage is down, the meningitis B dose three coverage is down, and the rotavirus dose two coverage is also down.

This is also a serious equalities issue. Children who grow up unprotected are disproportionately those living in poverty and from ethnic minority communities, and the gap in vaccination status is growing across the country. How has that been allowed to happen in modern Britain? The 2023 vaccination strategy under the last Government was intended to halt the decline, but it is clearly failing, with vaccination rates continuing to fall in the three years since. The WHO target of 95% coverage for all routine vaccination programmes was removed from NHS planning guidance in 2025-26, with the Secretary of State at the time saying,

“If everything is a priority, then nothing is”,

but the choice not to explicitly prioritise vaccinations is incredibly short-sighted.

My colleagues and I on the Health and Social Care Committee held a short inquiry into vaccination rates earlier this year, and we were, to be frank, shocked by the apparent complacency of leading NHS officials. There was no understanding of when it is hoped rates will return to WHO levels, or of whether and when our elimination status will be reached again. There is no target. This debate must be a call to arms to prioritise rebuilding our vaccination system as a matter of utmost urgency and to restore vaccination rates to 95% as soon as possible. Developing an effective vaccination system is not rocket science. Much of the existing strategy is relevant and positive, but we must acknowledge that we are off track.

The debate about what is wrong tends to focus on two key issues: access versus hesitancy. The access argument focuses on systemic, practical barriers that make it harder for people to get vaccinated, such as poor appointment availability, ineffective call and recall systems, lack of data linkage and fragmented health systems. On that argument, recent coverage decline is the sign of a system under strain, rather than a loss of confidence. Most patients and parents do trust vaccines: 85% of people polled by Ipsos in 2025 said that vaccines were safe. But people are busy—moving home, switching GPs—and they do not have endless time to navigate a confusing and increasingly fragmented NHS system.

The gap between MMR 1 and MMR 2 uptake is stark evidence of this failure, with MMR 1 coverage at five years at 91% and MMR 2 coverage at only 83%. The loss of contact is a system failure. Missed appointments should be chased, and families should retain close contact with trusted health professionals to guide them through the childhood vaccination schedule.

[Jen Craft (Thurrock) (Lab)]

My hon. Friend makes an excellent point. Our mini-inquiry into vaccination rates found that when rates decline or stall, the problem is often lack of trust and inability to access either trusted health professionals or the appointments themselves. Does he agree that improving the availability of vaccinations and advice from trusted health professionals is key to reversing this worrying trend?

[Danny Beales]

I agree. Those issues are clearly intertwined and cannot be separated.

Every contact should count. Shared digital records should identify, at the next GP appointment, pharmacy check-in, health visit or hospital appointment, where vaccines are missing. The system should be enabled, encouraged and paid to act, but this is currently not the case.

The hesitancy argument focuses on the growing prevalence of misinformation around vaccines and falling trust in vaccines and health institutions more broadly. Polling shows that these are not the most important factors numerically, but for the 15% of parents who have concerns, they matter. Evidence from the University of Manchester shows that this is especially important for certain population groups.

As my hon. Friend the Member for Thurrock (Jen Craft) just said, the barriers are multifaceted: poor trust and poor access go hand in hand, because the best way to build trust is through regular contact with known, trusted professionals. To maximise vaccine coverage, we need a system that can reliably identify and locate every child or patient missing their vaccination, repeatedly invite them for appointments and make attending appointments as easy as possible, with clear lines of responsibility when targets are missed. To do that effectively, the vaccination system needs adequate resourcing, accurate data and explicit accountability for meeting targets. Currently, we have none of that.

The Government have been acting. We are piloting health visits and community pharmacy delivery, although roll-out has been slow and it is unclear when national roll-out will be possible. Parents are now given access to their child’s records through the NHS app, work is under way to improve the consent process for vaccinating children in school. More is being done, and all of that is positive, but the Select Committee is not convinced that that will be enough to restore our vaccination levels to WHO standards, and neither are officials, who are unable to say whether and when levels will be restored.

Moving forward, what do we need? We need resourcing. Data I have obtained through parliamentary questions shows that in 2023-24 NHS England spent 0.51% of its total budget, or £852 million, on vaccination, down from 0.65%, or £989 million, in 2022-23. The very year the strategy released, funding was cut. We also need to be honest about what improvement will cost. Vaccinating the last 10% or 15% of any population is not the same task as vaccinating the first 80%, because of deprivation, language barriers and housing instability. All families affected by those factors need more contact with clinicians, and GPs simply do not have the resources to do the necessary outreach.

We need to fund not just new medicines and drugs, but their roll-out. We should be using lifetime parental consent to increase uptake of school-age vaccinations, and developing efficient, convenient and ongoing catch-up opportunities in schools, shopping centres, nurseries and family hubs. The school-age immunisation service should be operating a check-and-offer approach at every contact.

For the last 15%, we should be willing to fund what actually works: explicit payments to GPs for outreach programmes for underserved communities, including funding for multiple contact attempts, data cleaning, and non-responder tracking, with incentives linked to real outcomes. We should be training healthcare professionals and community groups to have difficult conversations with confidence and making far better use of our community pharmacy network, which is rooted in local areas.

We also need clear accountability; the buck has to stop somewhere locally and nationally, with clear vaccination leads at both levels. Since the Lansley reforms in 2012 and the subsequent austerity cuts, lines of accountability have become blurred. From April 2027, integrated care boards will have greater responsibility for commissioning vaccination programmes locally, but who is overseeing the national strategy? That remains unclear. Who will require corrective action when that is deemed to be necessary? That is not clear.

The removal of national targets was clearly a step backward for the system. Health officials and clinicians tell us that it is not always clear who is responsible when vaccination rates fall at delivery level in a given neighbourhood. We need a new national action plan that sets out concrete steps that will be taken to return coverage to our WHO targets.

We do not have all the systems in place to tell us reliably who has and has not been vaccinated. Data challenges run right through the system. Vaccines given in maternity settings, community pharmacy settings or school often fail to make their way back to the child’s GP surgery because the systems do not talk to each other. How can we expect call-and-recall strategies to work if clinicians do not reliably know which children need to be called?

Lastly, on hesitancy, we need to tackle misinformation, regulate it online and hold the peddlers of harmful and potentially deadly misinformation to account. Social media companies must step up their game in bringing down anti-vax information and providing clear, evidence-based health information instead.

I know much of this is not easy, but that is why it requires genuine commitment and prioritisation. I thank the Minister for listening; will she outline whether the Government accept that the situation is unacceptable and that urgent action is needed, and whether a clear timeline for meeting the WHO targets can and should be agreed by the NHS? If we are to set a timeline, will a clear action plan be outlined to set us on the path back to 95% of all children being vaccinated, so that we can all see a welcome and vital return of our measles elimination status? We must ensure that every child is safe, that people of all ages get the vaccines they need, and that the UK is once again a global leader in vaccinations.